After a median follow-up of 12.4 years, this study showed that using a baseline annual measurement of CA125 with a 35 U/mL cut-off in combination with pelvic ultrasound does not result in decreased ovarian cancer mortality [11]. The gene discussed is MUC16; the disease is ovarian carcinoma.